CEACAM5 and gastric cancer: Levels of CEA, CA72-4 and CA19-9 displayed strong elevation in phase III/IV GC patients compared with those in phase I/II GC patients (Fig. 2D–F), suggesting the diagnostic efficiency of CEA, CA19-9 and CA72-4 was remarkably improved in late-stage GC.